Mouse Anti-TET2 Recombinant Antibody (CBYJT-2574) (CBMAB-T1744-YJ)

Basic Information
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Biological Process cell cycleSource:UniProtKB-KW
Biological Process chromatin organizationSource:UniProtKB-KW
Biological Process DNA demethylationSource:UniProtKB1 Publication
Biological Process histone H3-K4 trimethylationSource:UniProtKB1 Publication
Biological Process leukocyte differentiationSource:UniProtKB1 Publication
Biological Process myeloid cell differentiationSource:UniProtKB1 Publication
Biological Process oxidative demethylationSource:GO_Central1 Publication
Biological Process oxidative DNA demethylationSource:UniProtKB1 Publication
Biological Process positive regulation of transcription by RNA polymerase IISource:UniProtKB2 Publications
Biological Process protein O-linked glycosylationSource:UniProtKB1 Publication
Biological Process response to organic cyclic compoundSource:Ensembl
A myeloproliferative disorder characterized by abnormal proliferation of all hematopoietic bone marrow elements, erythroid hyperplasia, an absolute increase in total blood volume, but also by myeloid leukocytosis, thrombocytosis and splenomegaly.
Myelodysplastic syndrome (MDS):
A heterogeneous group of closely related clonal hematopoietic disorders. All are characterized by a hypercellular or hypocellular bone marrow with impaired morphology and maturation, dysplasia of the myeloid, megakaryocytic and/or erythroid lineages, and peripheral blood cytopenias resulting from ineffective blood cell production. Included diseases are: refractory anemia (RA), refractory anemia with ringed sideroblasts (RARS), refractory anemia with excess blasts (RAEB), refractory cytopenia with multilineage dysplasia and ringed sideroblasts (RCMD-RS); chronic myelomonocytic leukemia (CMML) is a myelodysplastic/myeloproliferative disease. MDS is considered a premalignant condition in a subgroup of patients that often progresses to acute myeloid leukemia (AML).
Immunodeficiency 75 (IMD75):
An autosomal recessive immunologic disorder characterized by recurrent infections, mainly viral and affecting the respiratory tract, immunodeficieny, immune dysregulation, and the development of lymphoproliferative disorders, including lymphoma.
In contrast, another group reports GlcNAcylation by OGT in mouse ortholog.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols
Related Products
Rabbit Anti-TET2 Recombinant Antibody (D6B9Y) (CAT#: CBMAB-CP3094-LY)
Mouse Anti-TET2 (N-terminus) Recombinant Antibody (CBFYM-3155) (CAT#: CBMAB-M3352-FY)
Mouse Anti-TET2 Recombinant Antibody (CBT4311) (CAT#: V2LY-0625-LY1450)
Mouse Anti-TET2 Recombinant Antibody (CBYJT-2576) (CAT#: CBMAB-T1746-YJ)
Mouse Anti-TET2 Recombinant Antibody (CBYJT-2578) (CAT#: CBMAB-T1748-YJ)
Mouse Anti-TET2 Recombinant Antibody (CBYJT-2579) (CAT#: CBMAB-T1749-YJ)
Rabbit Anti-TET2 Recombinant Antibody (D9K3E) (CAT#: CBMAB-CP2737-LY)
Mouse Anti-TET2 Recombinant Antibody (CBYJT-2577) (CAT#: CBMAB-T1747-YJ)
Mouse Anti-TET2 Recombinant Antibody (CBYJT-2575) (CAT#: CBMAB-T1745-YJ)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
